世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Cell Culture Supplements Market Size, Share & Trends Analysis Report By Product (Protein-Based & Recombinant Supplements, Chemically Defined Supplements), By Application (Cell & Gene Therapy, Drug Discovery), By End-use, By Region, And Segment Forecasts, 2025 - 2033
Cell Culture Supplements Market Summary The global cell culture supplements market size was estimated at USD 2.53 billion in 2024 and is projected to reach USD 7.14 billion by 2033, growing at ... もっと見る
SummaryCell Culture Supplements Market SummaryThe global cell culture supplements market size was estimated at USD 2.53 billion in 2024 and is projected to reach USD 7.14 billion by 2033, growing at a CAGR of 12.74% from 2025 to 2033. This growth is driven by increasing demand for biopharmaceuticals, advancements in cell culture technology, and the rising focus on personalized medicine and regenerative therapies. Advancements in 3D Cell Culture and Organoid Models The growing adoption of 3D cell culture systems and organoid technologies significantly drives market demand for global cell culture supplements. Unlike conventional 2D cultures, 3D models accurately represent in vivo cellular environments, allowing researchers to study complex biological processes such as tissue development, cancer metastasis, and drug responses better. Organoids, in particular, have become vital tools in regenerative medicine and disease modeling, as they replicate the architecture and function of real human organs. For instance, a study published in Scientific Reports in July 2025 detailed the advancements in organoid-based models for infectious disease research. These 3D cell culture systems, derived from stem cells, offer more physiologically relevant human organ simulations than traditional 2D cultures. The study underscores the potential of organoid technology to accelerate drug discovery and reduce reliance on animal models. These advanced models require highly specific culture conditions and specialized supplements, including growth factors, extracellular matrix proteins, and defined media components to support cell differentiation, viability, and function. Pharmaceutical companies, biotech firms, and academic institutions increasingly turn to these innovative models to improve drug discovery efficiency and reduce dependence on animal testing. As a result, the demand for cell culture supplements tailored to complex systems like 3D cultures and organoids is expected to grow significantly, reinforcing the segment’s position as a critical enabler of next-generation biomedical research and therapeutic development. Rapid Growth in Regenerative Medicine and Stem Cell Research The expanding regenerative medicine and stem cell research field is a major driver boosting the global cell culture supplements industry. Regenerative medicine focuses on repairing or replacing damaged tissues and organs by harnessing the body’s healing mechanisms, often through stem cell-based therapies. Stem cells possess the unique ability to self-renew and differentiate into multiple cell types, making them invaluable for treating various conditions, including neurodegenerative diseases, cardiovascular disorders, and injuries. For instance, a clinical trial reported in The New England Journal of Medicine in June 2025 announced a significant advancement in type 1 diabetes treatment. Their study demonstrated that a single infusion of lab-grown pancreatic islet cells enabled patients to produce sufficient insulin independently. Within a year, 10 out of 12 participants no longer required supplemental insulin, marking a potential paradigm shift in diabetes management. Culturing these delicate stem cells requires highly specialized supplements that maintain their pluripotency or multipotency. These supplements provide essential nutrients, growth factors, cytokines, and signaling molecules that promote cell proliferation, viability, and controlled differentiation. The surge in clinical trials and increasing regulatory approvals of stem cell therapies worldwide are accelerating the demand for reliable and scalable cell culture systems. Tissue engineering and personalized medicine approaches rely heavily on optimized cell culture conditions supported by advanced supplements. This trend is expected to sustain strong growth in the market, as supplements play a crucial role in ensuring the success and safety of emerging regenerative treatments and stem cell applications. Global Cell Culture Supplements Market Report Segmentation This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell culture supplements market report on the basis of product, application, end use, and region: • Product Outlook (Revenue, USD Million, 2021 - 2033) • Serum-based Supplements • Protein-based & Recombinant Supplements • Chemically Defined Supplements • Others • Application Outlook (Revenue, USD Million, 2021 - 2033) • Biopharmaceutical Manufacturing • Cell & Gene Therapy • Drug Discovery • Others • End Use Outlook (Revenue, USD Million, 2021 - 2033) • Cell Culture Media Manufacturers • Pharmaceutical & Biotechnology Companies • CDMOs/ CMOs & CROs • Academic & Research Institutes • Regional Outlook (Revenue, USD Million, 2021 - 2033) • North America o U.S. o Canada o Mexico • Europe o Germany o UK o France o Italy o Spain o Denmark o Sweden o Norway • Asia Pacific o China o Japan o India o South Korea o Australia o Thailand • Latin America o Brazil o Argentina • MEA o South Africa o Saudi Arabia o UAE o Kuwait Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Market Definitions 1.2.1. Product Segment 1.2.2. Application Segment 1.2.3. End Use Segment 1.3. Information Analysis 1.3.1. Market formulation & data visualization 1.4. Data Validation & Publishing 1.5. Information Procurement 1.5.1. Primary Research 1.6. Information or Data Analysis 1.7. Market Formulation & Validation 1.8. Market Model 1.9. Total Market: CAGR Calculation 1.10. Objectives 1.10.1. Objective 1 1.10.2. Objective 2 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Snapshot 2.3. Competitive Insights Landscape Chapter 3. Cell Culture Supplements Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook. 3.2. Market Dynamics 3.2.1. Market driver analysis 3.2.1.1. Advancements in 3D cell culture and organoid models 3.2.1.2. Rapid growth in regenerative medicine and stem cell research 3.2.2. Market restraint analysis 3.2.2.1. High cost of GMP-grade and specialty supplements 3.2.2.2. Regulatory and standardization challenges 3.3. Cell Culture Supplements Market Analysis Tools 3.3.1. Industry Analysis - Porter’s 3.3.2. PESTEL Analysis Chapter 4. Cell Culture Supplements Market: Product Estimates & Trend Analysis 4.1. Segment Dashboard 4.2. Global Cell Culture Supplements Market Product Movement Analysis 4.3. Global Cell Culture Supplements Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million) 4.4. Serum-Based Supplements 4.4.1. Serum-Based Supplements market estimates and forecasts 2021 to 2033 (USD Million) 4.5. Protein-Based & Recombinant Supplements 4.5.1. Protein-Based & Recombinant Supplements market estimates and forecasts 2021 to 2033 (USD Million) 4.6. Chemically Defined Supplements 4.6.1. Kits & reagents market estimates and forecasts 2021 to 2033 (USD Million) 4.7. Others 4.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million) Chapter 5. Cell Culture Supplements Market: Application Estimates & Trend Analysis 5.1. Segment Dashboard 5.2. Global Cell Culture Supplements Market Application Movement Analysis 5.3. Global Cell Culture Supplements Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million) 5.4. Biopharmaceutical Manufacturing 5.4.1. Biopharmaceuticals manufacturing market estimates and forecasts 2021 to 2033 (USD Million) 5.5. Cell & Gene Therapy 5.5.1. Cell & gene therapy market estimates and forecasts 2021 to 2033 (USD Million) 5.6. Drug Discovery 5.6.1. Drug discovery market estimates and forecasts 2021 to 2033 (USD Million) 5.7. Others 5.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million) Chapter 6. Cell Culture Supplements Market: End Use Estimates & Trend Analysis 6.1. Segment Dashboard 6.2. Global Cell Culture Supplements Market End Use Movement Analysis 6.3. Global Cell Culture Supplements Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million) 6.4. Cell Culture Media Manufacturers 6.4.1. Cell culture media manufacturers companies market estimates and forecasts 2021 to 2033 (USD Million) 6.5. Pharmaceutical & Biotechnology Companies 6.5.1. Pharmaceuticals & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million) 6.6. CDMOs/ CMOs & CROs 6.6.1. CDMOs/ CMOs & CROs market estimates and forecasts 2021 to 2033 (USD Million) 6.7. Academic & Research Institutes 6.7.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million) Chapter 7. Cell Culture Supplements Market: Regional Estimates & Trend Analysis 7.1. Regional Market Share Analysis, 2023 & 2033 7.2. Regional Market Dashboard 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033: 7.4. North America 7.4.1. U.S. 7.4.1.1. Key country dynamics 7.4.1.2. Competitive scenario 7.4.1.3. U.S. market estimates and forecasts 2021 to 2033 (USD Million) 7.4.2. Canada 7.4.2.1. Key country dynamics 7.4.2.2. Competitive scenario 7.4.2.3. Canada market estimates and forecasts 2021 to 2033 (USD Million) 7.4.3. Mexico 7.4.3.1. Key country dynamics 7.4.3.2. Competitive scenario 7.4.3.3. Mexico market estimates and forecasts 2021 to 2033 (USD Million) 7.5. Europe 7.5.1. UK 7.5.1.1. Key country dynamics 7.5.1.2. Competitive scenario 7.5.1.3. UK market estimates and forecasts 2021 to 2033 (USD Million) 7.5.2. Germany 7.5.2.1. Key country dynamics 7.5.2.2. Competitive scenario 7.5.2.3. Germany market estimates and forecasts 2021 to 2033 (USD Million) 7.5.3. France 7.5.3.1. Key country dynamics 7.5.3.2. Competitive scenario 7.5.3.3. France market estimates and forecasts 2021 to 2033 (USD Million) 7.5.4. Italy 7.5.4.1. Key country dynamics 7.5.4.2. Competitive scenario 7.5.4.3. Italy market estimates and forecasts 2021 to 2033 (USD Million) 7.5.5. Spain 7.5.5.1. Key country dynamics 7.5.5.2. Competitive scenario 7.5.5.3. Spain market estimates and forecasts 2021 to 2033 (USD Million) 7.5.6. Norway 7.5.6.1. Key country dynamics 7.5.6.2. Competitive scenario 7.5.6.3. Norway market estimates and forecasts 2021 to 2033 (USD Million) 7.5.7. Sweden 7.5.7.1. Key country dynamics 7.5.7.2. Competitive scenario 7.5.7.3. Sweden market estimates and forecasts 2021 to 2033 (USD Million) 7.5.8. Denmark 7.5.8.1. Key country dynamics 7.5.8.2. Competitive scenario 7.5.8.3. Denmark market estimates and forecasts 2021 to 2033 (USD Million) 7.6. Asia Pacific 7.6.1. Japan 7.6.1.1. Key country dynamics 7.6.1.2. Competitive scenario 7.6.1.3. Japan market estimates and forecasts 2021 to 2033 (USD Million) 7.6.2. China 7.6.2.1. Key country dynamics 7.6.2.2. Competitive scenario 7.6.2.3. China market estimates and forecasts 2021 to 2033 (USD Million) 7.6.3. India 7.6.3.1. Key country dynamics 7.6.3.2. Competitive scenario 7.6.3.3. India market estimates and forecasts 2021 to 2033 (USD Million) 7.6.4. Australia 7.6.4.1. Key country dynamics 7.6.4.2. Competitive scenario 7.6.4.3. Australia market estimates and forecasts 2021 to 2033 (USD Million) 7.6.5. South Korea 7.6.5.1. Key country dynamics 7.6.5.2. Competitive scenario 7.6.5.3. South Korea market estimates and forecasts 2021 to 2033 (USD Million) 7.6.6. Thailand 7.6.6.1. Key country dynamics 7.6.6.2. Competitive scenario 7.6.6.3. Thailand market estimates and forecasts 2021 to 2033 (USD Million) 7.7. Latin America 7.7.1. Brazil 7.7.1.1. Key country dynamics 7.7.1.2. Competitive scenario 7.7.1.3. Brazil market estimates and forecasts 2021 to 2033 (USD Million) 7.7.2. Argentina 7.7.2.1. Key country dynamics 7.7.2.2. Competitive scenario 7.7.2.3. Argentina market estimates and forecasts 2021 to 2033 (USD Million) 7.8. MEA 7.8.1. South Africa 7.8.1.1. Key country dynamics 7.8.1.2. Competitive scenario 7.8.1.3. South Africa market estimates and forecasts 2021 to 2033 (USD Million) 7.8.2. Saudi Arabia 7.8.2.1. Key country dynamics 7.8.2.2. Competitive scenario 7.8.2.3. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million) 7.8.3. UAE 7.8.3.1. Key country dynamics 7.8.3.2. Competitive scenario 7.8.3.3. UAE market estimates and forecasts 2021 to 2033 (USD Million) 7.8.4. Kuwait 7.8.4.1. Key country dynamics 7.8.4.2. Competitive scenario 7.8.4.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million) Chapter 8. Competitive Landscape 8.1. Company/Competition Categorization 8.2. Strategy Mapping 8.3. Company Market Position Analysis, 2024 8.4. Company Profiles/Listing 8.4.1. Merck KGaA 8.4.1.1. Company overview 8.4.1.2. Financial performance 8.4.1.3. Product/Service benchmarking 8.4.1.4. Strategic initiatives 8.4.2. Thermo Fisher Scientific Inc. 8.4.2.1. Company overview 8.4.2.2. Financial performance 8.4.2.3. Product/Service benchmarking 8.4.2.4. Strategic initiatives 8.4.3. HiMedia Laboratories 8.4.3.1. Company overview 8.4.3.2. Financial performance 8.4.3.3. Product/Service benchmarking 8.4.3.4. Strategic initiatives 8.4.4. Danaher 8.4.4.1. Company overview 8.4.4.2. Financial performance 8.4.4.3. Product/Service benchmarking 8.4.4.4. Strategic initiatives 8.4.5. Sartorius AG 8.4.5.1. Company overview 8.4.5.2. Financial performance 8.4.5.3. Product/Service benchmarking 8.4.5.4. Strategic initiatives 8.4.6. Corning Inc. 8.4.6.1. Company overview 8.4.6.2. Financial performance 8.4.6.3. Product/Service benchmarking 8.4.6.4. Strategic initiatives 8.4.7. R&D Systems (Bio-Techne) 8.4.7.1. Company overview 8.4.7.2. Financial performance 8.4.7.3. Product/Service benchmarking 8.4.7.4. Strategic initiatives 8.4.8. STEMCELL Technologies 8.4.8.1. Company overview 8.4.8.2. Financial performance 8.4.8.3. Product/Service benchmarking 8.4.8.4. Strategic initiatives 8.4.9. Repligen Corporation 8.4.9.1. Company overview 8.4.9.2. Financial performance 8.4.9.3. Product/Service benchmarking 8.4.9.4. Strategic initiatives 8.4.10. Proteintech Group, Inc 8.4.10.1. Company overview 8.4.10.2. Financial performance 8.4.10.3. Product/Service benchmarking 8.4.10.4. Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（バイオ薬物）の最新刊レポート
Grand View Research社の 生物分野 での最新刊レポート
本レポートと同じKEY WORD（supplements）の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
